Addiction as aberrant learning-evidence from parkinson's disease

Addiction

Volumn 107, Issue 2, 2012, Pages 248-250

  Dagher, Alain ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Addiction; D1; D2; Dopamine; Gambling; Levodopa; Parkinson's disease.

Indexed keywords

ANTIPARKINSON AGENT; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADDICTION; ARTICLE; DRUG EFFECT; HUMAN; PARKINSON DISEASE; PSYCHOLOGICAL ASPECT; REINFORCEMENT; SYNDROME;

ANTIPARKINSON AGENTS; DOPAMINE AGENTS; HUMANS; LEVODOPA; PARKINSON DISEASE; RECEPTORS, DOPAMINE; REINFORCEMENT (PSYCHOLOGY); SUBSTANCE-RELATED DISORDERS; SYNDROME;

EID: 84855930901     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03624.x     Document Type: Note

References (20)

1. Ambermoon P., Carter A., Hall W., Dissanayaka N., O'Sullivan J. Compulsive use of dopamine replacement therapy: a model for stimulant drug addiction? Addiction 2012; 107: 241-7.
2. Evans A. H., Pavese N., Lawrence A. D., Tai Y. F., Appel S., Doder M. etal. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 2006; 59: 852-8.
3. Nutt J. G., Carter J. H., Van Houten L., Woodward W. R. Short- and long-duration responses to levodopa during the first year of levodopa therapy. Ann Neurol 1997; 42: 349-55.
4. Dagher A., Robbins T. W. Personality, addiction, dopamine: insights from Parkinson's disease. Neuron 2009; 61: 502-10.
5. Weintraub D., Koester J., Potenza M. N., Siderowf A. D., Stacy M., Voon V. etal. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010; 67: 589-95.
6. Potenza M. N. Should addictive disorders include non-substance-related conditions? Addiction 2006; 101: 142-51.
7. Pontone G., Williams J. R., Bassett S. S., Marsh L. Clinical features associated with impulse control disorders in Parkinson disease. Neurology 2006; 67: 1258-61.
8. Weintraub D., Siderowf A. D., Potenza M. N., Goveas J., Morales K. H., Duda J. E. etal. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006; 63: 969-73.
9. O'Sullivan S. S., Lees A. J. Dopamine dysregulation syndrome. Olanow C. W., Stocchi F., Lang A. E., editors. Parkinson's Disease: Non-Motor and Non-Dopaminergic Features. Oxford, UK: Blackwell; 2011, p. 202-14.
10. Albin R. L., Young A. B., Penney J. B. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989; 12: 366-75.
11. Self D. W. Dopamine receptor subtypes in reward and relapse. Neve K. A., editor. The Dopamine Receptors. New York: Humana Press; 2009, p. 479-524.
12. Cohen M. X., Frank M. J. Neurocomputational models of basal ganglia function in learning, memory and choice. Behav Brain Res 2009; 199: 141-56.
13. Frank M. J., Hutchison K. Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphisms. Neuroscience 2009; 164: 131-40.
14. Shen W., Flajolet M., Greengard P., Surmeier D. J. Dichotomous dopaminergic control of striatal synaptic plasticity. Science 2008; 321: 848-51.
15. Collins G. T., Woods J. H. Influence of conditioned reinforcement on the response-maintaining effects of quinpirole in rats. Behav Pharmacol 2009; 20: 492-504.
16. Volkow N. D., Fowler J. S., Wang G. J., Hitzemann R., Logan J., Schlyer D. J. etal. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993; 14: 169-77.
17. Dalley J. W., Fryer T. D., Brichard L., Robinson E. S., Theobald D. E., Laane K. etal. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007; 315: 1267-70.
18. Morgan D., Grant K. A., Gage H. D., Mach R. H., Kaplan J. R., Prioleau O. etal. Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat Neurosci 2002; 5: 169-74.
19. Johnson P. M., Kenny P. J. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci 2010; 13: 635-41.
20. Buckholtz J. W., Treadway M. T., Cowan R. L., Woodward N. D., Li R., Ansari M. S. etal. Dopaminergic network differences in human impulsivity. Science 2010; 329: 532.